Vijaya Diagnostic [VIJAYA] vs Metropolis [METROPOLIS] Detailed Stock Comparison
Vijaya Diagnostic
NSE
Loading...
Metropolis
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Vijaya Diagnostic wins in 11 metrics, Metropolis wins in 8 metrics, with 0 ties. Vijaya Diagnostic appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Vijaya Diagnostic | Metropolis | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 68.97 | 73.56 | Vijaya Diagnostic |
| Price-to-Book Ratio | 12.99 | 8.41 | Metropolis |
| Debt-to-Equity Ratio | 39.99 | 15.30 | Metropolis |
| PEG Ratio | 3.01 | 4.23 | Vijaya Diagnostic |
| EV/EBITDA | 35.59 | 50.99 | Vijaya Diagnostic |
| Profit Margin (TTM) | 21.04% | 10.83% | Vijaya Diagnostic |
| Operating Margin (TTM) | 27.99% | 15.26% | Vijaya Diagnostic |
| EBITDA Margin (TTM) | 27.99% | 15.26% | Vijaya Diagnostic |
| Return on Equity | 17.90% | 10.86% | Vijaya Diagnostic |
| Return on Assets (TTM) | 11.23% | 7.76% | Vijaya Diagnostic |
| Free Cash Flow (TTM) | $1.29B | $1.94B | Metropolis |
| Dividend Yield | 0.30% | N/A | N/A |
| 1-Year Return | 10.43% | 2.28% | Vijaya Diagnostic |
| Price-to-Sales Ratio (TTM) | 14.55 | 7.97 | Metropolis |
| Enterprise Value | $103.78B | $112.77B | Metropolis |
| EV/Revenue Ratio | 14.55 | 8.03 | Metropolis |
| Gross Profit Margin (TTM) | 88.61% | 78.05% | Vijaya Diagnostic |
| Revenue per Share (TTM) | $70 | $273 | Metropolis |
| Earnings per Share (Diluted) | $14.63 | $29.37 | Metropolis |
| Beta (Stock Volatility) | -0.10 | 0.09 | Vijaya Diagnostic |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Vijaya Diagnostic vs Metropolis Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Vijaya Diagnostic | 1.29% | -1.30% | -9.99% | 5.97% | 10.05% | -5.17% |
| Metropolis | 0.05% | 0.88% | 12.21% | 30.52% | 38.12% | 6.42% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Vijaya Diagnostic | 10.43% | 163.27% | 60.73% | 60.73% | 60.73% | 60.73% |
| Metropolis | 2.28% | 56.00% | 22.55% | 125.51% | 125.51% | 125.51% |
Performance & Financial Health Analysis: Vijaya Diagnostic vs Metropolis
| Metric | VIJAYA | METROPOLIS |
|---|---|---|
| Market Information | ||
| Market Cap | ₹103.79B | ₹111.94B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 191,896 | 49,464 |
| 90 Day Avg. Volume | 445,588 | 136,874 |
| Last Close | ₹1,007.80 | ₹2,188.50 |
| 52 Week Range | ₹740.00 - ₹1,275.00 | ₹1,315.00 - ₹2,318.30 |
| % from 52W High | -20.96% | -5.60% |
| All-Time High | ₹1,275.00 (Jan 13, 2025) | ₹3,579.90 (Dec 27, 2021) |
| % from All-Time High | -20.96% | -38.87% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.20% | 0.23% |
| Quarterly Earnings Growth | 0.22% | 0.19% |
| Financial Health | ||
| Profit Margin (TTM) | 0.21% | 0.11% |
| Operating Margin (TTM) | 0.28% | 0.15% |
| Return on Equity (TTM) | 0.18% | 0.11% |
| Debt to Equity (MRQ) | 39.99 | 15.30 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹77.65 | ₹256.94 |
| Cash per Share (MRQ) | ₹22.90 | ₹22.83 |
| Operating Cash Flow (TTM) | ₹2.04B | ₹1.90B |
| Levered Free Cash Flow (TTM) | ₹1.43B | ₹1.45B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.30% | N/A |
| Last 12-Month Dividend | ₹3.00 | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Vijaya Diagnostic vs Metropolis
| Metric | VIJAYA | METROPOLIS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 68.97 | 73.56 |
| Forward P/E | 50.65 | 44.27 |
| PEG Ratio | 3.01 | 4.23 |
| Price to Sales (TTM) | 14.55 | 7.97 |
| Price to Book (MRQ) | 12.99 | 8.41 |
| Market Capitalization | ||
| Market Capitalization | ₹103.79B | ₹111.94B |
| Enterprise Value | ₹103.78B | ₹112.77B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 14.55 | 8.03 |
| Enterprise to EBITDA | 35.59 | 50.99 |
| Risk & Other Metrics | ||
| Beta | -0.10 | 0.09 |
| Book Value per Share (MRQ) | ₹77.65 | ₹256.94 |
Financial Statements Comparison: Vijaya Diagnostic vs Metropolis
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | VIJAYA | METROPOLIS |
|---|---|---|
| Revenue/Sales | ₹1.88B | ₹3.86B |
| Cost of Goods Sold | ₹214.13M | ₹847.23M |
| Gross Profit | ₹1.67B | ₹3.01B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹526.44M | ₹589.12M |
| EBITDA | ₹805.82M | ₹972.74M |
| Pre-Tax Income | ₹522.07M | ₹612.30M |
| Income Tax | ₹136.18M | ₹159.85M |
| Net Income (Profit) | ₹385.89M | ₹452.45M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | VIJAYA | METROPOLIS |
|---|---|---|
| Cash & Equivalents | ₹128.01M | ₹394.76M |
| Total Current Assets | ₹3.07B | ₹3.46B |
| Total Current Liabilities | ₹1.63B | ₹2.94B |
| Long-Term Debt | ₹2.96B | ₹1.12B |
| Total Shareholders Equity | ₹7.99B | ₹13.35B |
| Retained Earnings | N/A | ₹10.31B |
| Property, Plant & Equipment | ₹7.24B | ₹2.80B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | VIJAYA | METROPOLIS |
|---|---|---|
| Operating Cash Flow | ₹282.28M | ₹491.22M |
| Capital Expenditures | ₹-648.48M | ₹-45.26M |
| Free Cash Flow | ₹-321.75M | ₹320.68M |
| Debt Repayment | ₹-2.72M | ₹830,000 |
| Common Stock Repurchase | N/A | ₹-35.55M |
Short Interest & Institutional Ownership Analysis
| Metric | VIJAYA | METROPOLIS |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 191,896 | 49,464 |
| Average Daily Volume (90 Day) | 445,588 | 136,874 |
| Shares Outstanding | 102.64M | 51.80M |
| Float Shares | 47.92M | 25.96M |
| % Held by Insiders | 0.53% | 0.50% |
| % Held by Institutions | 0.43% | 0.43% |
Dividend Analysis & Yield Comparison: Vijaya Diagnostic vs Metropolis
| Metric | VIJAYA | METROPOLIS |
|---|---|---|
| Last 12-Month Dividend | ₹3.00 | ₹0.00 |
| Last 12-Month Dividend Yield | 0.30% | N/A |
| 3-Year Avg Annual Dividend | ₹1.67 | ₹4.00 |
| 3-Year Avg Dividend Yield | 0.19% | 0.42% |
| 3-Year Total Dividends | ₹5.00 | ₹12.00 |
| Ex-Dividend Date | Aug 29, 2025 | Nov 17, 2023 |